NC S444

Adds over 40 new synthetic opioids to Schedule I, including AP-237 variants and numerous U-47700 analogues (such as 2-Naphthyl U-47700, Cyclopropyl U-47700, and difluoro variants)

Creates a new Schedule I category for "nitazene derivatives" covering the N-substituted benzimidazole structural class, with exceptions for commercial manufacturing, medical prescriptions, and recognized research institutions

Adds bromazolam to Schedule I depressants and expands the definition of substituted cathinones to include cycloalkyl and methoxybenzyl group substitutions

Expands Schedule I synthetic cannabinoid classifications by adding six new structural categories: oxindoles, indole acetamides, indazole acetaldehydes, and pyrazoles, along with updated definitions for existing indole and indazole carboxamide classes

Makes technical corrections to existing controlled substance listings, including updated nomenclature for fluorofentanyl variants and spelling corrections for anabolic steroids (dehydrochloromethyltestosterone, mesterolone)